301 related articles for article (PubMed ID: 28413936)
1. Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity.
Nielsen NP; Wiig EH; Bäck S; Gustafsson J
Nord J Psychiatry; 2017 May; 71(4):296-303. PubMed ID: 28413936
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
[TBL] [Abstract][Full Text] [Related]
3. Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD.
Nielsen NP; Wiig EH
J Atten Disord; 2013 Apr; 17(3):187-93. PubMed ID: 22210798
[TBL] [Abstract][Full Text] [Related]
4. AQT cognitive speed and processing efficiency differentiate adults with and without ADHD: a preliminary study.
Nielsen NP; Wiig EH
Int J Psychiatry Clin Pract; 2011 Sep; 15(3):219-27. PubMed ID: 22121933
[TBL] [Abstract][Full Text] [Related]
5. Differentiating depression and ADHD without depression in adults with processing-speed measures.
Martiny K; Nielsen NP; Wiig EH
Acta Neuropsychiatr; 2020 Oct; 32(5):237-246. PubMed ID: 32338233
[TBL] [Abstract][Full Text] [Related]
6. Visual attention in adults with attention-deficit/hyperactivity disorder before and after stimulant treatment.
Low AM; Vangkilde S; le Sommer J; Fagerlund B; Glenthøj B; Jepsen JRM; Bundesen C; Petersen A; Habekost T
Psychol Med; 2019 Nov; 49(15):2617-2625. PubMed ID: 30560740
[TBL] [Abstract][Full Text] [Related]
7. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
8. Processing speed as a marker to stimulant effect in clinical sample of children with high functioning autism spectrum disorder.
Peled J; Cassuto H; Berger I
Nord J Psychiatry; 2020 Apr; 74(3):163-167. PubMed ID: 31686565
[No Abstract] [Full Text] [Related]
9. Naming speed performance and stimulant effects indicate effortful, semantic processing deficits in attention-deficit/hyperactivity disorder.
Tannock R; Martinussen R; Frijters J
J Abnorm Child Psychol; 2000 Jun; 28(3):237-52. PubMed ID: 10885682
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder.
Bedard AC; Ickowicz A; Tannock R
J Child Adolesc Psychopharmacol; 2002; 12(4):301-9. PubMed ID: 12625990
[TBL] [Abstract][Full Text] [Related]
11. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
12. Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate.
Liddle EB; Hollis C; Batty MJ; Groom MJ; Totman JJ; Liotti M; Scerif G; Liddle PF
J Child Psychol Psychiatry; 2011 Jul; 52(7):761-71. PubMed ID: 21073458
[TBL] [Abstract][Full Text] [Related]
13. Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.
Low AM; le Sommer J; Vangkilde S; Fagerlund B; Glenthøj B; Sonuga-Barke E; Habekost T; Jepsen JRM
Int J Neuropsychopharmacol; 2018 Nov; 21(11):997-1006. PubMed ID: 30124878
[TBL] [Abstract][Full Text] [Related]
14. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
Rhodes SM; Coghill DR; Matthews K
J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
[TBL] [Abstract][Full Text] [Related]
15. An additive model for relations between AQT single- and dual-dimension naming speed.
Nielsen NP; Wiig EH
Percept Mot Skills; 2011 Apr; 112(2):499-508. PubMed ID: 21667758
[TBL] [Abstract][Full Text] [Related]
16. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
[TBL] [Abstract][Full Text] [Related]
17. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
[TBL] [Abstract][Full Text] [Related]
18. Predicting methylphenidate response in attention deficit hyperactivity disorder: a preliminary study.
Johnston BA; Coghill D; Matthews K; Steele JD
J Psychopharmacol; 2015 Jan; 29(1):24-30. PubMed ID: 25237119
[TBL] [Abstract][Full Text] [Related]
19. An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
Brackenridge R; McKenzie K; Murray GC; Quigley A
Res Dev Disabil; 2011; 32(6):2797-804. PubMed ID: 21700419
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
